Empallo is a groundbreaking MIT spinoff dedicated to "Saving hearts." Leveraging AI technology, the company specializes in bringing value-based care to heart failure management. With operations spanning across multiple states, Empallo is poised for success as it enters its third year as an innovator in the management of HF.
Operating within the Information Technology sector, Empallo's headquarters are situated in the United States. The latest milestone for the company was a significant $50.00KPre Seed Round investment on 27 April 2023, with backing from The Roux Institute at Northeastern University.
Empallo's dynamic approach to heart failure management, coupled with the support of esteemed investors, positions the company as a compelling prospect for venture capital consideration. The potential for technological advancement and impact in the healthcare sector makes Empallo a promising investment opportunity.